ASC-520

N/A

Report date: 2024/12/20 13:40:46

Base Information

Drug NameASC-520
Drug Alias NameASC-520
ClassificationCell and gene therapy > Gene therapy > Gene editing
Mechanisms of ActionGene transference
TargetsNot applicable
Therapy Area/Indicationsbeta-Thalassemia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesASC Therapeutics
China Registration ClassN/A

Develop Information

Active CompaniesASC Therapeutics
Inactive CompaniesN/A
Active Indicationsbeta-Thalassemia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A